White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly
WASHINGTON (AP) — The Biden administration is taking a victory lap after federal officials inked deals with drug companies to lower the price for 10 of Medicare’s most popular and costliest drugs, but shared few immediate details
US undercounts bird flu in cattle as farmers shun testing
By Leah Douglas and Tom Polansek WASHINGTON/CHICAGO (Reuters) – The U.S. bird-flu outbreak in dairy cattle is much larger than official figures suggest due to farmers’ reluctance to test their animals and risk the economic consequences of
Doctors struggle to get Wegovy for older Americans with heart disease
By Patrick Wingrove NEW YORK (Reuters) – Older Americans are having little success getting prescriptions for weight-loss drug Wegovy covered by Medicare despite the federal healthcare program’s decision to pay for patients with obesity at risk of
Factbox-Top Medicare drugs headed for price cuts
By Patrick Wingrove (Reuters) – The Biden administration selected 10 prescription medicines for unprecedented price negotiations by the Medicare health program for older Americans that covers 66 million people. Below are details on the drugs, including their
US expects $6 billion savings from first Medicare drug price negotiations
By Patrick Wingrove and Trevor Hunnicutt WASHINGTON (Reuters) – The U.S. government will save $6 billion in the first year from lower prices the Biden administration negotiated on 10 top-selling prescription drugs for the Medicare health program
UN envoy says South Sudan is not ready to hold its first post-independence elections in December
UNITED NATIONS (AP) — South Sudan is not ready to hold its first post-independence elections in December and political players are discussing whether voting should be held this year, the U.N.’s top envoy in the troubled African